Patent AU-2019240547-B2 (AU)
Title: Method for separation of dopaminergic neural cells and pharmaceutical composition comprising dopaminergic neural cells for treatment of Parkinson's disease
Inventor: KIM DONG-WOOK
IPC: A61K35/30
Filed: 2019-04-26
Granted: 2021-08-12
Abstract: All 1i-7]-"1 f)4j ]j. a11111111111111111li1111l7iili 
(10) --I 7lld 
(43) A]I -- 7l 1''-07 
2019 l 116 7 o (07.11.2019) WIPOIPCT W O 2019/212201 Al 
(51) 14 l j *lT': (PARK, Sanghyun); 01195 A]i&^1 4'H °UN -V27 
C12N5/0793 (2010.01) A61P25/16 (2006.01) 70 19, 210-1103, Seoul (KR). 7J (KIM, Jongwan); 
A61K 35/30 (2006.01) 02814 Ai a'A1 >, " i i 267 8,206-507, Seoul (KR).  
PCT/KR2019/005058 (CHO, Myung Soo); 01488 A]1 A] 
(21) 1t 350, 402-1209, Seoul (KR).  
(22) #]1-%i: 2019 V 4 N 26 V (26.04.2019) (74) FIZ ?l: 'rI (YOON, Dae Woong); 08793 Ai A^ A 
(25) -11 -: 4Oi T 1922,301-,Seoul(KR).  
(26) `67}] 0-: W-i (81) A] 51 N ( 1 A A17}1 Mq 7}1d£ W 
(30) -- ' • -- :l 1-V -i -&I}0): AE, AG, AL, AM, AO, AT, 
10-2018-0050918 2018 V 5 N 2 " (02.05.2018) KR AU, AZ, BA, BB, BG, BH, BN, 
BR, BW, BY, BZ, CA, CH, 
10-2018-0048784 20198k 45 25 (250.201) K(R CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, 
10-2019-0048784 2019V4 4 N 25 (25.04.2019) K(R EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, HN, HR, HU, 
(71) Oil: (T) 0ll 1 MO9A q- (S-BIOMEDICS) [KR/ ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, 
KR]; 04797,A1 A^1 2 V T 126 728, 4, Seoul LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, 
(KR). MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, 
PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, 
(72) 1¶}: 7dl94 (KIM, Dong-Wook); 04095 A ~ SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 
T {1T X 107, 102-702, Seoul (KR). r -- (YOO, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.  
Jeong-Eun); 11685 71 ]5 ^ Ma 681-11, 
Gyeonggi-do (KR). 01% (LEE, Dongjin); 06077 A (84) Al -( 1 AA]171} M± , 7}12 ] 1 
~714 NW. 609, 2-507, Seoul (KR). 4t 1E1 I 0j1O}1): ARIPO (BW, GH, GM, KE, 
(54) Title: METHOD FOR ISOLATING DOPAMINE NEURONS AND PHARMACEUTICAL COMPOSITION FOR TREATING 
PARKINSON'S DISEASE, CONTAINING DOPAMINE NEURONS ISOLATED USING SAME 
(54- -1o 11o 6:5 Rj ILI Al K 1] 01T I 1 o>N- 0 -9--at0101 -V 9 4II All -K-NAp - ~~4-at P 
= 11 -- j~ 
50* 30 * 
40 
20 
30 
200 
10 
0 - -- -, --
-- Unsorted TPBG+ Unsorted TPBG+ 
*P<0,05, **PC0.01,** P<0.001 
(57) Abstract: The present invention relates to a method for isolating doparme neurons and a pharmaceutical composition for treating 
Parkinson's disease, containing doparme neurons isolated using same. The method for isolating doparme neurons comprises a step 
for isolating trophoblast glycoprotein (TPBG)-positive doparme neurons, such that the doparme neurons isolated by the method have 
increased cell efficacy when transplanted and enhanced transplantation safety so as to be effectively used for cell transplantation for 
Cthe treatment of Parkinson's disease.  
Al~_q _VA ?& l WWM , 1 It} 71 - Ail 1 " - E,l t TPBG(Trophoblast glycoprotein)-O, } JL 
- 01T15Y ~ I'" 0 ls1a 
0 3TlJ01 ;A -R71Z.111-] LN l 1TO--IA -- F(Jl
W O 2019/212201 A 1 ||11||||||||||||||IHI|I|111|1|I|I||I|HI |I|IDI |ID ||I|||||||||||||||||||||||| 
LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, 
ZW), ^ elA]} 4(AM, AZ, BY, KG, KZ, RU, TJ, TM),  
ei (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fl, 
FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, 
MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI 
(BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, 
MR, NE, SN, TD, TG).  
o71]: 
- -%AlLA1i7(- Al 21-(3)) 
All A] 1 A4 11( 5.2(a))